Alan Blake is the founder of Nuclein. Nuclein has raised $20M in total funding. Latest round: Series B. Backed by Trinity Private Equity Group.
Alan Blake is a co-founder and Chief Executive Officer of Nuclein, LLC, a molecular diagnostics company based in Austin, Texas. He founded the company in 2017 to create sample-to-answer diagnostic technology. Blake has led Nuclein through its growth, including a $14 million Series B funding round in March 2021.
Full founder directory · Investor directory · Company funding database · Fundraising library